- Home
- INKT vs RGS Comparison
INKT vs RGS Comparison
Compare INKT & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- RGS
- Stock Information
- Founded
- INKT 2017
- RGS 1922
- Country
- INKT United States
- RGS United States
- Employees
- INKT N/A
- RGS N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- RGS Other Consumer Services
- Sector
- INKT Health Care
- RGS Consumer Discretionary
- Exchange
- INKT Nasdaq
- RGS Nasdaq
- Market Cap
- INKT 69.2M
- RGS 70.8M
- IPO Year
- INKT 2021
- RGS 1991
- Fundamental
- Price
- INKT $14.20
- RGS $30.04
- Analyst Decision
- INKT Buy
- RGS
- Analyst Count
- INKT 3
- RGS 0
- Target Price
- INKT $37.50
- RGS N/A
- AVG Volume (30 Days)
- INKT 28.2K
- RGS 12.2K
- Earning Date
- INKT 11-13-2025
- RGS 11-12-2025
- Dividend Yield
- INKT N/A
- RGS N/A
- EPS Growth
- INKT N/A
- RGS 20.23
- EPS
- INKT N/A
- RGS 46.10
- Revenue
- INKT N/A
- RGS $210,134,000.00
- Revenue This Year
- INKT N/A
- RGS N/A
- Revenue Next Year
- INKT N/A
- RGS N/A
- P/E Ratio
- INKT N/A
- RGS $0.68
- Revenue Growth
- INKT N/A
- RGS 3.52
- 52 Week Low
- INKT $4.56
- RGS $15.00
- 52 Week High
- INKT $76.00
- RGS $31.50
- Technical
- Relative Strength Index (RSI)
- INKT 47.12
- RGS 57.17
- Support Level
- INKT $14.01
- RGS $29.21
- Resistance Level
- INKT $15.25
- RGS $30.50
- Average True Range (ATR)
- INKT 0.70
- RGS 0.77
- MACD
- INKT 0.01
- RGS -0.24
- Stochastic Oscillator
- INKT 24.88
- RGS 47.10
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
About RGS Regis Corporation
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.